bone medical ltd (BNE:ASX)

Executive Profile*

Background*

Mr. Peter Franklin Young, MBA has been the Chief Executive Officer of Bone Medical Ltd. since March 1, 2011 and serves as its Managing Director. Mr. Young served as the Chief Executive Officer and President of Ikano Therapeutics Inc. (Formerly Intranasal Therapeutics, Inc.) since April 2007. He served as the Chief Executive Officer of Alphavax Inc. since 1999 and served as its President. He was employed by various Glaxo entities for a period of over 10 years. Mr. Young ... served as Vice President of HIV and Opportunistic Infection at Glaxo Wellcome, where he was responsible for combined global commercial and product development and oversaw a five-fold expansion in the latter part of the 1990s. He has 25 years of experience in the global pharmaceutical industry, including senior commercial, general management, and development positions at Abbott International and Glaxo Wellcome. Mr. Young also held leadership positions at Abbott International including Pharmaceutical Director. He began his career & held Product Management & Sales positions at Merrell Dow Pharmaceuticals. He serves as the Chairman of North Carolina Biosciences Organization. He serves as the Chairman of NC BIO, a member of the national BIO board of directors, Chairmen-Elect of the Council for Entrepreneurial Development. Mr. Young served as the Chairman of Alphavax Inc. since 2001. He has been an Executive Director of Bone Medical Ltd. since April 1, 2011. He served as a Director of Biotechnology Industry Organization. He served as a Director of Alphavax Inc. He served as a Director of Memory Pharmaceuticals Corp. from September 28, 2004 to 2009. Mr. Young holds B.A and a Master of Business Administration from Indiana University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
BNE:AU	A$0.00 AUD	0.00

COMPETITOR COMPENSATION